Kinnate Biopharma Inc. Annual Return On Assets in % from 2021 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Kinnate Biopharma Inc. annual/quarterly Return On Assets history and growth rate from 2021 to 2023.
  • Kinnate Biopharma Inc. Return On Assets for the quarter ending December 31, 2022 was -37.1 %, a 59.6% decline year-over-year.
  • Kinnate Biopharma Inc. annual Return On Assets for 2023 was -54.7 %, a 47.3% decline from 2022.
  • Kinnate Biopharma Inc. annual Return On Assets for 2022 was -37.1 %, a 59.6% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -54.7 -17.6 -47.3% Jan 1, 2023 Dec 31, 2023
2022 -37.1 -13.9 -59.6% Jan 1, 2022 Dec 31, 2022
2021 -23.3 Jan 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.